'We just learned through a FOIA request that $PRED received a letter from the FDA MONTHS AGO, effectively putting them on notice of potential violations of FDA compliance. We found ZERO disclosure of this letter to investors' -Hindenburg Research Tweets
Benzinga Newsdesk - Jul 30, 2019, 9:38AM